ANZCA, along with peak diabetes, obesity and gastroenterological bodies, has produced clinical practice recommendations for patients using GLP-1/GIP receptor agonists.

ANZCA’s statement on desflurane supports the continued education and actions to reduce usage.

The national shortage of IV fluid bags across multiple suppliers in Australia is ongoing and anticipated to continue until March 2025.

The following advice to anaesthetists is provided by the Chair of ANZCA’s Safety and Quality Committee, Associate Professor Joanna Sutherland in response to a widespread shortage of intravenous fluids.

Important information for ANZCA trainees and supervisors on changes to Appendix 2 of the anaesthesia training program curriculum.

Now More Than Ever

The ANZCA Training Program is moving towards a model of competency-based education as part of the training program evolution.

We are proud to congratulate four of our faculty fellows who have been awarded ANZCA research grants for 2025, three of whom have received honorary named awards for their outstanding contributions.

ANZCA Foundation prestigious named research awards; Prime Minister's Prize for Science; ANZCA Foundation grants and named research awards decided; 2026 research grant applications opening soon; ANZCA Foundation subscriptions appeal

Read an interview with specialist international medical graduate Dr Kiran Venkatesulu from Royal Perth Hospital.